ArticleRMD open2024

Correction: Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.